Showing results (181-190 of 308) with videos related to
Sort By:
Pageof 31
Cancers|December 10, 2021
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral TherapyJae Seung Lee, Hyun Woong Lee, Tae Seop Lim, et al.Cancers|February 15, 2022
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter StudyJae Seung Lee, Hyun Woong Lee, Tae Seop Lim, et al.Journal of Viral Hepatitis|October 23, 2019
An observational study on long-term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarateTae Seop Lim, Jae Seung Lee, Beom Kyung Kim, et al.Journal of Gastroenterology and Hepatology|September 29, 2024
Incidence of metabolic dysfunction-associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort studyKunhee Kim, Yaeji Lee, Jae Seung Lee, et al.Journal of Gastroenterology and Hepatology|November 19, 2016
Gamma-glutamyl transpeptidase-to-platelet ratio is an independent predictor of hepatitis B virus-related liver cancerYong Eun Park, Beom Kyung Kim, Jun Yong Park, et al.International Journal of Radiation Oncology, Biology, Physics|October 12, 2010
Gastroduodenal complications after concurrent chemoradiation therapy in patients with hepatocellular carcinoma: endoscopic findings and risk factorsYoung Eun Chon, Jinsil Seong, Beom Kyung Kim, et al.Atherosclerosis|February 23, 2017
Liver fibrosis assessed with transient elastography is an independent risk factor for ischemic strokeSeung Up Kim, Dongbeom Song, Ji Hoe Heo, et al.European Journal of Internal Medicine|December 8, 2020
Negligible HCC risk during stringently defined untreated immune-tolerant phase of chronic hepatitis BHye Won Lee, Young Eun Chon, Beom Kyung Kim, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 13, 2026
Dynamic Risk Modelling of Hepatocellular CarcinomaZhenning Yu, Shyna Zhuoying Gunalan, Nicole Shu Ying Tang, et al.British Journal of Clinical Pharmacology|November 27, 2020
Pharmacokinetics and safety of evogliptin in hepatically impaired patientsTaegon Hong, Byung Hak Jin, Choon Ok Kim, et al.Pageof 31